Triple
T5981415
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Donepezil |
E133125
|
entity |
| Predicate | hasINN |
P23160
|
FINISHED |
| Object | donepezil |
E133125
|
NE FINISHED |
Named-entity recognition
Before disambiguation, gpt-5-mini classified whether the object phrase is a named entity — the step behind the object's NE type shown above.
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: donepezil | Statement: [Donepezil, hasINN, donepezil]
Disambiguation candidates (1 decision)
The exact options the model was shown at each disambiguation step, with the option it chose highlighted — the evidence behind this triple's disambiguated ids.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: donepezil Context triple: [Donepezil, hasINN, donepezil]
-
A.
Donepezil
chosen
Donepezil is a cholinesterase inhibitor medication primarily used to treat cognitive symptoms of Alzheimer's disease.
-
B.
rivastigmine
Rivastigmine is a cholinesterase inhibitor medication used to manage symptoms of mild to moderate dementia, particularly in Alzheimer's and Parkinson's disease.
-
C.
Namenda
Namenda is a prescription medication used to treat moderate to severe Alzheimer's disease by regulating the activity of glutamate in the brain.
-
D.
memantine
Memantine is a medication that helps manage symptoms of moderate to severe Alzheimer's disease by modulating glutamate activity in the brain.
-
E.
levodopa
Levodopa is a cornerstone medication for managing Parkinson’s disease symptoms by replenishing the brain’s depleted dopamine levels.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69c0086f45e8819098f73dd16d45ec9d |
elicitation | completed |
| NER | batch_69c04a6921b081908a6f6323d5c7a062 |
ner | completed |
| NED1 | batch_69c0e42174a88190b8b40cbc7815911f |
ned_source_triple | completed |
Created at: March 22, 2026, 4:04 p.m.